Abstract:The present study compares the pharmacokinetics of amoxicillin and clavulanate potassium suspension (200 mg/28.5 mg) during fasting and postprandial conditions, and the sample adds a stabilizer study. Two randomized, crossover trials were conducted in an open‐label, single‐center study (a fasting trial and a postprandial trial). In each part of the study, the subjects were randomly assigned to receive either test or reference products (200 mg/28.5 mg) in a 1:1:1 ratio, followed by the alternative products after a 7‐day washout period. Plasma amoxicillin and clavulanic acid concentrations were analyzed by liquid chromatography–tandem mass spectrometry. WinNonlin software was used to evaluate the pharmacokinetic parameters (noncompartmental model). The formulations were considered bioequivalent if the geometric means of area under the plasma concentration–time curve (AUC) and maximum plasma concentration (Cmax) of amoxicillin and clavulanic acid were within the predetermined bioequivalence range established by average bioequivalence (ABE) or reference‐scaled ABE. Tolerability was assessed throughout the study. The postprandial trial and the fasting study each had 12 volunteers. Under fasting and postprandial conditions, the 90%CI for the ratio of geometric means of amoxicillin of Cmax, AUC from time 0 to the last measurable concentration, and AUC from time 0 to infinity were within the ABE acceptance limits (80%‐125%); the geometric means of clavulanic acid of Cmax (critbound, –0.03; point estimate, 1.07) were within the reference‐scaled ABE acceptance limits, and the AUC from time 0 to the last measurable concentration and AUC from time 0 to infinity were within the ABE acceptance limits (80%–125%). Time to maximum concentration of amoxicillin was delayed 1.0 hour with high‐fat meals compared to fasting conditions. Meantime, high‐fat meals decreased the exposure of clavulanic acid by nearly 40%. No serious adverse events were found among the subjects. The bioequivalence of test and reference amoxicillin and clavulanate potassium for suspension was validated in this study under fasting and postprandial conditions.

Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.

The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil

Effect of food on absorption of cefpodoxime proxetil oral suspension in adults

Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses

The bioavailability of cefpodoxime proxetil tablets relative to an oral solution

IMPROVEMENT OF BIOAVAILABILITY OF CEFUROXIME AXETIL ORAL SUSPENSION BY INCLUSION COMPLEXATION METHOD

Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil

Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil

Effect of timing of food on absorption of cefpodoxime proxetil

Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine

Gastro-retentive dosage form for improving bioavailability of Cefpodoxime proxetil in rats

Cefpodoxime pharmacokinetics in children: effect of food

Effects of Food on Absorption of Ozagrel after Oral Administration in Healthy Volunteers

Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology

Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation

Pharmacokinetics of Amoxicillin and Clavulanate Potassium for Suspension (200 mg/28.5 mg) in Healthy Subjects: Sample Add Stabilizer Study and Food Effects

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances

A Review of the Pharmacokinetics of Cefpodoxime Proxetil

Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability

Pharmacokinetics and Bioequivalence of Ranitidine and Bismuth Derived from Two Compound Preparations

Effect of relative bioavailability of domperidone maleate combined with antacids in healthy volunteers